scholarly journals A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆

2010 ◽  
Vol 37 (5) ◽  
pp. 1191-1197 ◽  
Author(s):  
Jun Nakajima ◽  
Tomohiro Murakawa ◽  
Takeshi Fukami ◽  
Shigenori Goto ◽  
Toru Kaneko ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Phase I ◽  
Cancer Patients ◽  
Adoptive Immunotherapy ◽  
Phase I Study ◽  
Γδ T Cells ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

2007 ◽  
Vol 56 (10) ◽  
pp. 1637-1644 ◽  
Author(s):  
Martin Sebastian ◽  
Bernward Passlick ◽  
Hilke Friccius-Quecke ◽  
Michael Jäger ◽  
Horst Lindhofer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

IMMUNEPOTENT CRP (bovine dialyzable leukocyte extract) adjuvant immunotherapy: a phase I study in non-small cell lung cancer patients

Cytotherapy ◽  
2008 ◽  
Vol 10 (5) ◽  
pp. 490-496 ◽  
Author(s):  
M.A. Franco-Molina ◽  
E. Mendoza-Gamboa ◽  
P. Zapata-Benavides ◽  
M.E. Vera-García ◽  
P. Castillo-Tello ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Adjuvant Immunotherapy ◽  
Lung Cancer Patients

Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol®) and carboplatin in non-small cell lung cancer patients

2000 ◽  
Vol 11 (9) ◽  
pp. 687-694 ◽  
Author(s):  
Jetske M Meerum Terwogt ◽  
Olaf van Tellingen ◽  
Vinodh R Nannan Panday ◽  
Manon T Huizing ◽  
Jan HM Schellens ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Cremophor El ◽  
Small Cell Lung ◽  
Lung Cancer Patients

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

2004 ◽  
Vol 53 (1) ◽  
pp. 25-32 ◽  
Author(s):  
Giuseppe Frasci ◽  
Pasquale Comella ◽  
Renato Thomas ◽  
Maurizio Di Bonito ◽  
Liliana Lapenta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients

scholarly journals Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients

2018 ◽  
Vol 32 (3) ◽  
pp. 367-375 ◽  
Author(s):  
Hyojin Kim ◽  
Hyun Jung Kwon ◽  
Yeon Bi Han ◽  
Soo Young Park ◽  
Eun Sun Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
T Cells ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Therapeutic Response ◽  
Cd8 T Cell ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Ratio ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document